1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF606 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA TP73 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA KMT2E CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA GTF3C6 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA POLR1D CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA AL358852.1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA ZNF142 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA BOLA2 CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA TRIOBP CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA FBXO41 CTRPv2 pan-cancer AAC 0.18 2e-05
Download CSV